The difference between once-daily and twice-daily dosing is noticeably but not dramatically so for most applications
Neuregulin and IGF1 can act synergistically to increase mitochondrial biogenesis and mtDNA replication in primary Schwann cells, which requires both the ERK and PI3K signaling pathways (Ribeiro et al., 2014)
Interestingly, knockdown of CAV1 in cancer cells resulted in attenuated tumour growth, decreased proliferation, and impaired migration and invasion [189, 190], suggesting a tumour-promoting role of CAV1 in cancer cells
By supplying this potent peptide, we empower formulators to create products that restore youthful skin function, addressing consumer demand for effective anti-aging and reparative solutions
Their combined effect in non-diabetic adults has not been tested in a phase 3 trial
We want to be transparent about where the research stands